Recordati offers both prescription and OTC products in a wide range of therapeutic areas.
Recordati’s flagship product is ZANIDIP® (lercanidipine), a latest generation calcium-channel blocker for the treatment of hypertension. It is a lipophilic dihydropyridine, discovered and entirely developed by Recordati, with the following characteristics: natural once a day, potent, long-lasting vasodilatory activity, highly vasoselective with gradual onset, smooth and uniform blood pressure lowering activity and improved tolerability over other dihydropyridines.
We offer a wide range of innovative pharmaceuticals in specific therapeutic areas:
- Antibiotics and Antivirals
- Central nervous system
- Genito-urinary system
- Muscolo-skeletal disorders and pain therapy
- Obstetics and Gynaecology
- OTC (non-prescription pharmaceuticals)